CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-09 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −5,833 | 11,667 | ||
| 2023-02-09 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −4,967 | 4,967 | ||
| 2023-02-09 | DICICCO WENDY F Director | Option exercise | +3,000 | 7,400 | ||
| 2023-02-09 | DICICCO WENDY F Director | Option exercise · Restricted Stock Units | −3,000 | 0 | ||
| 2023-02-09 | Landis John B. Director | Option exercise | +3,000 | 11,400 | ||
| 2023-02-09 | Landis John B. Director | Option exercise · Restricted Stock Units | −3,000 | 0 | ||
| 2023-02-09 | ANDO GORAN Director | Option exercise | +3,250 | 8,150 | ||
| 2023-02-09 | ANDO GORAN Director | Option exercise · Restricted Stock Units | −3,250 | 0 | ||
| 2023-02-09 | Duker Jay S. President and COO | Option exercise | +7,000 | 28,402 | ||
| 2023-02-09 | Duker Jay S. President and COO | Option exercise | +4,967 | 33,369 | ||
| 2023-02-09 | Duker Jay S. President and COO | Shares withheld for taxes | −2,426 | $4.17 | $10K | 30,943 |
| 2023-02-09 | Duker Jay S. President and COO | Shares withheld for taxes | −1,722 | $4.17 | $7K | 29,221 |
| 2023-02-09 | Duker Jay S. President and COO | Option exercise · Restricted Stock Units | −7,000 | 14,000 | ||
| 2023-02-09 | Duker Jay S. President and COO | Option exercise · Restricted Stock Units | −4,967 | 4,967 | ||
| 2023-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise | +4,967 | 23,089 | ||
| 2023-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise | +5,000 | 28,089 | ||
| 2023-02-09 | Jones David Scott SVP & Chief Commercial Officer | Shares withheld for taxes | −1,483 | $4.17 | $6K | 26,606 |
| 2023-02-09 | Jones David Scott SVP & Chief Commercial Officer | Shares withheld for taxes | −1,473 | $4.17 | $6K | 25,133 |
| 2023-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Restricted Stock Units | −5,000 | 10,000 | ||
| 2023-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,967 | 4,967 |
Page 25 of 31 · 616 trades